Skip to main content
Top
Published in: Annals of Hematology 4/2021

01-04-2021 | Iron Deficiency | Original Article

Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants

Authors: Eugenia Mendoza, Ximena Duque, Segundo Moran, Gloria Martínez-Andrade, Elba Reyes-Maldonado, Samuel Flores-Huerta, Homero Martinez

Published in: Annals of Hematology | Issue 4/2021

Login to get access

Abstract

The purpose of this study was to describe the changes in iron status indicators at 6 and 12 months of age, controlling by inflammation by measuring alpha-1 acid glycoprotein (AGP). This longitudinal study included 48 healthy-term singleton infants with birth weight ≥ 2500 g, born in hospitals of the Mexican Institute for Social Security. Complete blood count, ferritin, soluble transferrin receptor (sTfR), hepcidin, and AGP were measured in blood at 6 and 12 months of age. sTfR/ferritin ratio and total body iron (TBI) stores were calculated. Hemoglobin and sTfR/ferritin ratio increased with age, while ferritin and TBI decreased. In infants without inflammation, hepcidin, sTfR, and MVC did not show significant changes from 6 to 12 months of age, while ferritin and TBI decreased. In infants with inflammation, hepcidin, TBI, and ferritin levels increased, while hemoglobin and sTfR/ferritin ratio decreased. MVC and sTfR did not change significantly in the presence or absence of inflammation. Hepcidin concentration correlated positively and significantly with ferritin and TBI stores and showed significant negative correlation with sTfR/ferritin ratio. Our study showed that, in absence of inflammation and ID, during the first year of life, physiological changes occur in hemoglobin and ferritin levels as well as in indicators derived from ferritin and sTfR; in contrast, hepcidin and sTfR did not show significant change. However, hepcidin concentration was lower in infants with ID and was higher when inflammation was present, supporting that infants have a functional hepcidin response to changes in iron stores.
Literature
1.
go back to reference WHO (2015) The global prevalence of anaemia in 2011 Geneva. World Health Organization WHO (2015) The global prevalence of anaemia in 2011 Geneva. World Health Organization
4.
go back to reference Duque X, Flores-Hernández S, Flores-Huerta S, Méndez-Ramírez I, Muñoz S, Turnbull B, Martínez-Andrade G, Ramos RI, González-Unzaga M, Mendoza ME, Martínez H (2007) Prevalence of anemia and deficiency of iron, folic acid, and zinc in children younger than 2 years of age who use the health services provided by the Mexican Social Security Institute. BMC Public Health 7(1):345. https://doi.org/10.1186/1471-2458-7-345CrossRefPubMedPubMedCentral Duque X, Flores-Hernández S, Flores-Huerta S, Méndez-Ramírez I, Muñoz S, Turnbull B, Martínez-Andrade G, Ramos RI, González-Unzaga M, Mendoza ME, Martínez H (2007) Prevalence of anemia and deficiency of iron, folic acid, and zinc in children younger than 2 years of age who use the health services provided by the Mexican Social Security Institute. BMC Public Health 7(1):345. https://​doi.​org/​10.​1186/​1471-2458-7-345CrossRefPubMedPubMedCentral
5.
go back to reference Shamah-Levy T, Vielma-Orozco E, Heredia-Hernández O, Romero-Martínez M, Mojica-Cuevas J, Cuevas-Nasu L, Santaella-Castell JA, Rivera-Domarco J (2020) Encuesta Nacional de Salud y Nutrición 2018–19: Resultados Nacionales. Instituto Nacional de Salud Pública, Cuernavaca, Morelos Shamah-Levy T, Vielma-Orozco E, Heredia-Hernández O, Romero-Martínez M, Mojica-Cuevas J, Cuevas-Nasu L, Santaella-Castell JA, Rivera-Domarco J (2020) Encuesta Nacional de Salud y Nutrición 2018–19: Resultados Nacionales. Instituto Nacional de Salud Pública, Cuernavaca, Morelos
6.
go back to reference WHO (2020) Global anaemia reduction efforts among women of reproductive age: impact, achievement of targets and the way forward for optimizing efforts. Geneva: World Health Organization. Licence: CC BY-NCSA 3.0 IGO WHO (2020) Global anaemia reduction efforts among women of reproductive age: impact, achievement of targets and the way forward for optimizing efforts. Geneva: World Health Organization. Licence: CC BY-NCSA 3.0 IGO
13.
go back to reference WHO (2007) Centers for disease control and prevention. Assessing the iron status of populations. WHO Press Geneva, Switzerland WHO (2007) Centers for disease control and prevention. Assessing the iron status of populations. WHO Press Geneva, Switzerland
19.
go back to reference Uijterschout L, Swinkels DW, Domellöf M, Lagerqvist C, Huding C, Tjalsma H, Vos R, Goudoever JB, Brus F (2014) Serum hepcidin measured by immunochemical and mass-spectrometric methods and their correlation with iron status indicators in healthy children aged 0.5–3 y. Pediatr Res 76(4):409–414. https://doi.org/10.1038/pr.2014.109CrossRefPubMed Uijterschout L, Swinkels DW, Domellöf M, Lagerqvist C, Huding C, Tjalsma H, Vos R, Goudoever JB, Brus F (2014) Serum hepcidin measured by immunochemical and mass-spectrometric methods and their correlation with iron status indicators in healthy children aged 0.5–3 y. Pediatr Res 76(4):409–414. https://​doi.​org/​10.​1038/​pr.​2014.​109CrossRefPubMed
22.
go back to reference Aggett PJ, Agostini C, Axelsson I, Bresson J-L, Goulet O, Hernell O, Koletzko B, Lafeber HL, Michaelsen KF, Micheli J-L, Rigo J, Szajewska H, Weaver LT (2002) Iron metabolism and requirements in early childhood: do we know enough?: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 34(4):337–345. https://doi.org/10.1097/00005176-200204000-00003CrossRefPubMed Aggett PJ, Agostini C, Axelsson I, Bresson J-L, Goulet O, Hernell O, Koletzko B, Lafeber HL, Michaelsen KF, Micheli J-L, Rigo J, Szajewska H, Weaver LT (2002) Iron metabolism and requirements in early childhood: do we know enough?: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 34(4):337–345. https://​doi.​org/​10.​1097/​00005176-200204000-00003CrossRefPubMed
25.
go back to reference WHO (2006) Multicentre Growth Reference Study Group. WHO Child Growth Standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization.312 pages WHO (2006) Multicentre Growth Reference Study Group. WHO Child Growth Standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization.312 pages
27.
go back to reference WHO (2008) Indicators for assessing infant and young child feeding practices: Part 1: definitions: conclusions of a consensus meeting held 6–8 November 2007 in Washington DC, USA WHO (2008) Indicators for assessing infant and young child feeding practices: Part 1: definitions: conclusions of a consensus meeting held 6–8 November 2007 in Washington DC, USA
30.
go back to reference Pérez Acosta A (2019) Puntos de corte en la concentración de ferritina para detectar bajas reservas corporales de hierro, en niños mexicanos durante el primer año de vida. Universidad Nacional Autonoma de Mexico, CDMX Pérez Acosta A (2019) Puntos de corte en la concentración de ferritina para detectar bajas reservas corporales de hierro, en niños mexicanos durante el primer año de vida. Universidad Nacional Autonoma de Mexico, CDMX
33.
go back to reference Suárez-López L, Campero L, De la Vara-Salazar E, Rivera-Rivera L, Hernández-Serrato MI, Walker D, Lazcano-Ponce E (2013) Sociodemographic and reproductive characteristics associated with the increase of cesarean section practice in Mexico. Salud Publica Mex 55(2):S225–S234CrossRef Suárez-López L, Campero L, De la Vara-Salazar E, Rivera-Rivera L, Hernández-Serrato MI, Walker D, Lazcano-Ponce E (2013) Sociodemographic and reproductive characteristics associated with the increase of cesarean section practice in Mexico. Salud Publica Mex 55(2):S225–S234CrossRef
45.
go back to reference Drakesmith H ( 2016) Next-generation biomarkers for iron status In: Vevey & Karger (ed) Next-generation nutritional biomarkers to guide better health care: Nestlé Nutrition Institute Workshop Series vol 84. Basel, Switzerland pp 59–69. https://doi.org/10.1159/000436955 Drakesmith H ( 2016) Next-generation biomarkers for iron status In: Vevey & Karger (ed) Next-generation nutritional biomarkers to guide better health care: Nestlé Nutrition Institute Workshop Series vol 84. Basel, Switzerland pp 59–69. https://​doi.​org/​10.​1159/​000436955
50.
go back to reference Radboud University Nijmegen Medical Centre (2012) Hepcidin reference values WCX-TOF MS/ reference values for serum Hepcidin-25 in children aged 6 months to 3 years. http://hepcidinanalysis.com/. Accessed [Marzo 2019] Radboud University Nijmegen Medical Centre (2012) Hepcidin reference values WCX-TOF MS/ reference values for serum Hepcidin-25 in children aged 6 months to 3 years. http://​hepcidinanalysis​.​com/​. Accessed [Marzo 2019]
Metadata
Title
Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants
Authors
Eugenia Mendoza
Ximena Duque
Segundo Moran
Gloria Martínez-Andrade
Elba Reyes-Maldonado
Samuel Flores-Huerta
Homero Martinez
Publication date
01-04-2021
Publisher
Springer Berlin Heidelberg
Keyword
Iron Deficiency
Published in
Annals of Hematology / Issue 4/2021
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-021-04402-5

Other articles of this Issue 4/2021

Annals of Hematology 4/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.